News
Gold prices fell in holiday-thinned Asia trading after settling lower overnight, taking a breather after setting fresh record highs this week.
To make your life a little easier—whether you’re watching underneath the scorching sun in Indio or on your living room couch—we’ve sorted out what you need to know about Coachella weekend two set ...
If approved, Eylea would be the first treatment for RVO with 8-week dosing. The FDA target action date is Aug. 19, 2025.
The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for aflibercept injection 8mg for the treatment of macular edema following ...
FDA accepts Regeneron's sBLA for Eylea HD in RVO with priority review; QUASAR data supports monthly dosing, target action date set for August 2025.
SACRAMENTO – A search is on for a driver who crashed into a south Sacramento home and took off from the scene. The Sacramento ...
13h
Pharmaceutical Technology on MSNFDA to review Regeneron’s sBLA for aflibercept injection 8mgThe US Food and Drug Administration (FDA) has accepted Regeneron Pharmaceuticals’ supplemental biologics licence application ...
ClickFix malware tactic used by Iran, Russia, and North Korea from Nov 2024–Feb 2025 replaces payload delivery in major ...
"Gold prices reached a new all-time high today, solidifying their status as the preferred safe-haven asset in an increasingly ...
The sBLA seeks approval for Eylea HD for both the treatment of macular edema following retinal vein occlusion, and for ...
Pharmaceuticals announced that the U.S. Food and Drug Administration, FDA, has accepted for Priority Review the supplemental ...
The ECB is expected to reduce its benchmark lending rate by a quarter-point on Thursday. Data on interest-rate futures from the London Stock Exchange Group point to 95% odds of a cut, the seventh ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results